Showing results (11-20 of 193) with videos related to
Sort By:
Pageof 20
Revue D'Epidemiologie Et De Sante Publique|May 11, 2000
[A review of socio-behavioural studies on adherence to antiretroviral treatments: beyond biomedical models?]J P Moatti, B Spire, S DuranAnti-Cancer Drugs|January 16, 1999
The economic evaluation of hematopoietic growth factors in high-dose chemotherapyA G Le Corroller, J P MoattiBulletin Du Cancer|July 1, 1995
[Medical chemoprevention of cancers. From the point of view of social sciences]P Bourret, F Eisinger, J P MoattiInternational Journal of Technology Assessment in Health Care|December 11, 1986
The diffusion and use of diagnostic imaging equipment in France. The limits of regulationF Fagnani, J P Moatti, C WeillTransfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 5, 2000
[Economic analysis versus the principle of guaranteed safety in blood transfusion]J P Moatti, S Loubière, M RotilyThe British Journal of Nutrition|September 1, 1984
Absorption of electrolytes and volatile fatty acids in the hind-gut of the rabbit. Circadian rhythm of hind-gut electrolytes and plasma aldosteroneM Vernay, J Marty, J P MoattiGeneral and Comparative Endocrinology|June 1, 1985
[Plasma androgens and 17 beta-estradiol of the Pyrenean urodele Euproctus asper during the period of reproduction]M Clergue, J P Moatti, P MilhetGastroenterologie Clinique Et Biologique|January 5, 2001
[Medico-economic assessment of the therapeutic management of patients with hepatitis C]S Loubière, M Rotily, J P MoattiClinical Therapeutics|May 1, 1994
Impact of ondansetron and granisetron on chemotherapy-induced emesis in adults: the need for comparative pharmacoeconomic dataS Hedayati, J P Moatti, J F SeitzSocial Science & Medicine (1982)|June 1, 1994
Researcher-driven versus policy-driven economic appraisal of health technologies: the case of FranceJ P Moatti, C Chanut, J M BenechPageof 20